APTUS PHARMA LIMITED SME IPO Opens on 23rd September, 2025

• Total Issue Size Issue of 18,60,000 Equity Shares aggregating up to ₹ 1,302.00 Lakhs
• Price Band– Rs.65/- to Rs.70/- Per Share
• Face Value – Rs. 10 Per Share
• Lot Size 2000Equity Shares and in Multiples thereof
• Minimum Application size – Two lots per application, such that the minimum application size shall be above ₹ 2 lakhs.
• Listing on – SME Platform of BSE Limited (BSE SME) 

APTUS PHARMA LIMITED has announced its plan to go public with an Initial Public Offering (IPO)  opening on 23^rd September, 2025 and Closing on 25^th September, 2025 and to be listed on the BSE SME platform

APTUS PHARMA LIMITED

• Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model.
• Four distinct divisions for four distinct divisions 1) therapeutic segments 2) Aptus Pharma (Pioneer Division) 3) Aptus CD Care (Cardiac Diabetic Division) 4) Aptus Wellcare (Wellcare Division)
• As on March 31, 2025, product basket -194pharmaceutical formulations in more than eleven (11) therapeutic segments.
• Company has distribution network of more than 125 direct and Sub Distributers distributors and a sales team comprising more than 54 field personnel
• the Company has established centrally located warehouses spread over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat
• Company quality assurance framework includes real-time lab analysis of every batch during and after manufacturing, with testing conducted at affiliated certified laboratories
• Company ensures compliance with applicable WHO-GMP and cGMP norms.
• Company holds certifications issued by TQV Private Limited such as: ISO 9001:2015 ,  ISO 14001:2015, ISO 14001:2015 ,GMP & GDP

Mr. Tejash Maheshchandra Hathi, Managing Director ofAPTUS PHARMA LIMITED, said “I’m thrilled to announce our SME IPO listing, marking a significant milestone in our journey.”

Objects of the Issue

1. Capital Expenditure for Office Premises with furniture and Industrial Racks
2. Working Capital
3. General Corporate Purposes

Issue Structure

INTERACTIVE FINANCIAL SERVICES LIMITED is the Book Running Lead Manager (BRLM) to the Issue and BIGSHARE SERVICES PRIVATE LIMITED is the Registrar to the Issue.

Financials

Disclaimer: APTUS PHARMA LIMITED is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its Equity Shares and has filed the Red Herring Prospectus with the Registrar of Companies, on 13^thSeptember, 2025 and thereafter with SEBI and the Stock Exchange. The Red Herring Prospectus is available on the website of SME BSE at https://www.bsesme.com/PublicIssues/RHP.aspx. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the Prospectus including the section titled “Risk Factors” on page 28of the Red Herring Prospectus. 

Further, each Applicant where required agrees that such Applicant will not sell or transfer any Equity Shares or create any economic interest therein, including any off-shore derivative instruments, such as participatory notes, issued against the Equity Shares or any similar security, other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with applicable laws and legislations in each jurisdiction, including India.